Understanding the Benefits of Semaglutide for Diabetes Management with Levemir FlexTouch Semaglutide is renowned for its powerful hypoglycemic effects, making it a top choice for managing diabetes. As a GLP-1 receptor agonist, semaglutide enhances insulin secretion and suppresses glucagon secretion in a glucose-dependent manner by activating the GLP-1 receptor. It also increases glucose uptake in muscle and adipose tissue while inhibiting hepatic glucose production, delays gastric emptying, and suppresses appetite. Clinical Efficacy of Semaglutide Numerous clinical studies have confirmed the efficacy of semaglutide, showing it can reduce glycated hemoglobin (HbA1c) by 1.5% to 1.8% in patients with type 2 diabetes. Its hypoglycemic effect surpasses that of liraglutide, exenatide weekly preparations, and sitagliptin. Regardless of previous treatment methods or diabetes duration, semaglutide can significantly lower HbA1c, especially in patients with higher baseline levels. In ...
A knowledge community serving people with diabetes